Alnylam Pharmaceuticals, Inc.
8 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Alnylam Pharmaceuticals, Inc.
Federal lobbying records
Bills it lobbied onAll 4
HR 1672 Maintaining Investments in New Innovation Act25 reports · In committeeHR 946 ORPHAN Cures Act18 reports · In committeeS 1862 ORPHAN Cures Act11 reports · In committeeHR 4993 Joe Fiandra Access to Home Infusion Act of 20256 reports · Out of committeeLawmakers it funded or lobbiedAll 4
Brian FitzpatrickLeads 1 of these billsDonald DavisLeads 1 of these billsJohn BarrassoLeads 1 of these billsJohn JoyceLeads 1 of these billsEvery link on this map
The same connections as a table, with the reason each one is here.
| HR 1672 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 1672, “Maintaining Investments in New Innovation Act”, in 25 lobbying reports. | 25 reports |
| HR 946 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 946, “ORPHAN Cures Act”, in 18 lobbying reports. | 18 reports |
| S 1862 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named S 1862, “ORPHAN Cures Act”, in 11 lobbying reports. | 11 reports |
| HR 4993 | Bills it lobbied on | Alnylam Pharmaceuticals, Inc. named HR 4993, “Joe Fiandra Access to Home Infusion Act of 2025”, in 6 lobbying reports. | 6 reports |
| Brian Fitzpatrick | Lawmakers it funded or lobbied | Brian Fitzpatrick leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| Donald Davis | Lawmakers it funded or lobbied | Donald Davis leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| John Barrasso | Lawmakers it funded or lobbied | John Barrasso leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
| John Joyce | Lawmakers it funded or lobbied | John Joyce leads 1 bill Alnylam Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |